Gufic BioSciences announced the sad demise of Shrirang Vaidya (DIN: 03618800), Independent Director of the Company on 01 April 2024. Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 9.44% to Rs 22.26 crore in the quarter ended December 2023 as against Rs 20.34 crore during the previous quarter ended December 2022. Sales rose 13.70% to Rs 201.78 crore in the quarter ended December 2023 as against Rs 177.47 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales201.78177.47 14 OPM %18.0719.43 - PBDT33.7032.89 2 PBT29.5627.25 8 NP22.2620.34 9 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net profit of Gufic BioSciences rose 14.84% to Rs 23.21 crore in the quarter ended September 2023 as against Rs 20.21 crore during the previous quarter ended September 2022. Sales rose 22.90% to Rs 214.87 crore in the quarter ended September 2023 as against Rs 174.84 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales214.87174.84 23 OPM %18.3218.65 - PBDT35.2431.82 11 PBT30.9427.26 13 NP23.2120.21 15 Powered by Capital Market - Live News

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 9 November 2023.Powered by Capital Market - Live News